Clinical Trials Browser

Phase 1/2 × Melanoma × Filgrastim × Clear all

NCT00062036 2017-07-02

Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

Phase 1/2 Completed

Melanoma